Omeprazole Generic Will Stay: Schwarz Does Not Infringe Prilosec Patent
Executive Summary
Schwarz' omeprazole does not infringe AstraZeneca's Prilosec patents because the generic does not contain an alkaline reacting compound, a D.C. federal appeals court affirmed Dec. 11
You may also be interested in...
Teva, Ivax Move Closer To Marketing Generic Gabapentin
Teva and Ivax are moving into position to consider "at risk" launches of generic gabapentin (Pfizer's Neurontin)
Teva, Ivax Move Closer To Marketing Generic Gabapentin
Teva and Ivax are moving into position to consider "at risk" launches of generic gabapentin (Pfizer's Neurontin)
Neurontin, Rebetol Generics Could Be Affected By “Shared Exclusivity” Ruling
A federal court decision invalidating FDA's "shared exclusivity" policy for first-to-file ANDAs poses another potential complication to the launch of generic versions of Pfizer's Neurontin (gabapentin)